These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 217836)

  • 1. Mecillinam in urinary tract infections and in septicaemia.
    Frimodt-Møller N; Ravn TJ
    Infection; 1979; 7(1):35-7. PubMed ID: 217836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral amdinocillin for treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1983 Aug; 75(2A):82-4. PubMed ID: 6311010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mecillinam and ampicillin separately or combined in gram-negative septicemia.
    Ekwall E; Scheja A; Cronberg S; Ganrot-Norlin K; Jonsson M; Juhlin I; Kahlmeter G; Thorén A; Thulin KE; Tunevall G
    Infection; 1980; 8(1):37-40. PubMed ID: 6246006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of parenteral mecillinam in a chest hospital.
    Pines A; Raafat H; Khorasani MH; Sharma JC; Menday AP
    Curr Med Res Opin; 1981; 7(3):137-41. PubMed ID: 6260430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of clinical experience with amdinocillin monotherapy and comparative studies.
    Demos CH; Green E
    Am J Med; 1983 Aug; 75(2A):72-81. PubMed ID: 6311009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.
    Thulin E; Thulin M; Andersson DI
    EBioMedicine; 2017 Sep; 23():111-118. PubMed ID: 28855073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of intravenous mecillinam in patients with chronic urinary infection and reduced renal function].
    Wessel-Aas T; Svarva P
    Tidsskr Nor Laegeforen; 1981 Oct; 101(28):1573-5. PubMed ID: 6280334
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity of urinary-tract isolates to mecillinam and amoxycillin.
    Lancet; 1978 Feb; 1(8061):445. PubMed ID: 75472
    [No Abstract]   [Full Text] [Related]  

  • 9. A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
    Birgy A; Delecourt M; Geslain G; Desselas E; Caseris M; Magnan M; Mariani-Kurkdjian P; Bidet P; Bonacorsi S
    J Antimicrob Chemother; 2017 Jul; 72(7):1911-1914. PubMed ID: 28369441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary experience with parenteral mecillinam.
    Menday AP; Marsh BT
    Curr Med Res Opin; 1979; 6(3):221-8. PubMed ID: 230011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination amdinocillin and cefoxitin therapy of multiply-resistant Serratia marcescens urinary tract infections.
    Ward TT; Amon MB; Krause LK
    Am J Med; 1983 Aug; 75(2A):85-9. PubMed ID: 6311011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lampri N; Galani I; Poulakou G; Katsarolis I; Petrikkos G; Giamarellou H; Souli M
    J Antimicrob Chemother; 2012 Oct; 67(10):2424-8. PubMed ID: 22665388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecillinam resistance and outcome of pivmecillinam treatment in uncomplicated lower urinary tract infection in women.
    Monsen TJ; Holm SE; Ferry BM; Ferry SA
    APMIS; 2014 Apr; 122(4):317-23. PubMed ID: 24738161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mecillinam.
    Lancet; 1978 Feb; 1(8058):252-3. PubMed ID: 74673
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study on clinical effectiveness of mecillinam and pivmecillinam versus ampicillin in acute urinary infections (author's transl)].
    Seppelt U; Bertermann H; Sonntag HG
    Arzneimittelforschung; 1982; 32(5):569-71. PubMed ID: 6285939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
    BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with pivmecillinam in patients with recurrent bacteriuria.
    Bresky B; Lincoln K
    J Int Med Res; 1982; 10(3):179-82. PubMed ID: 6284565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mecillinam resistance in Escherichia coli: dissociation of growth inhibition and morphologic change.
    Barbour AG; Mayer LW; Spratt BG
    J Infect Dis; 1981 Jan; 143(1):114-21. PubMed ID: 6260864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivmecillinam plus pivampicillin in urinary tract infections. A double-blind comparison with pivmecillinam alone in hospitalized patients.
    Saltvedt EP; Schøyen R
    Infection; 1982 Jan; 10(1):21-2. PubMed ID: 6279521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serotype and resistance pattern of the intestinal Escherichia coli flora during travel. Results from a trial of mecillinam as a prophylactic against travellers' diarrhoea.
    Stenderup J; Orskov I; Orskov F
    Scand J Infect Dis; 1983; 15(4):367-73. PubMed ID: 6318304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.